基于术前CT的胃癌根治术后无复发生存风险评分系统的开发与验证
该研究回顾性纳入2017年10月至2022年1月间346例接受根治性手术的胃癌患者,利用多因素Cox回归在推导集(213例)中筛选出ctEMVI、ctBorrmann分型、内脏肥胖、肌少症和NLR五个独立预测因子构建风险评分,并在独立测试集(133例)中验证,其c-index为0.741,优于病理T分期的0.673(p=0.021)。
要点
- 术前CT风险评分在测试集中c-index为0.741,优于病理T分期的0.673(p=0.021)。
- ctEMVI、ctBorrmann分型、内脏肥胖、肌少症和NLR是RFS的独立预测因子。
- 该评分可有效将患者分为低风险和高风险组。
核心结论
- 所开发的术前风险评分系统能够预测胃癌患者根治性切除术后的无复发生存。
研究设计与样本
- 回顾性纳入连续接受根治性手术并经手术证实的胃癌患者,术前均行CT扫描,推导集213例,独立测试集133例,共346例;采用多因素Cox回归在推导集中筛选变量并构建风险评分。
诊断标准与关键数值
- 风险评分包含ctEMVI、ctBorrmann分型、内脏肥胖、肌少症和NLR五个变量;在测试集中c-index为0.741,病理T分期的c-index为0.673(p=0.021)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The objective of this study was to establish and validate a preoperative risk scoring system that incorporated both clinical and computed tomography(CT) variables to predict recurrence-free survival (RFS) in gastric cancer(GC) patients who underwent curative resection.
METHOD: We retrospectively included consecutive patients with surgically confirmed GC who underwent preoperative CT scans between October 2017 and January 2022. Multivariate Cox regression analysis was employed in the derivation set to identify clinical and CT variables associated with RFS and to construct a risk score. This risk score was subsequently validated in an independent test set.
RESULTS: A total of 346 patients were included in the study, with 213 in the derivation set and 133 in the test set. Five variables, namely ctEMVI, ctBorrmann, visceral obesity, sarcopenia, and NLR, were independently associated with RFS. In the test set, the preoperative risk score exhibited a c-index of 0.741, which outperformed the predictive accuracy of pathological tumor staging (c-index of 0.673, p = 0.021) at various time points. The preoperative risk score effectively stratified patients into low and high-risk groups.
CONCLUSION: The developed preoperative risk scoring system demonstrated the ability to predict RFS following curative resection in GC patients.
引用
- Zhu Z, Gong H, Gu J, et al. Development and validation of a preoperative CT-based risk scoring system for predicting recurrence-free survival in patients undergoing curative surgery for gastric cancer. Eur J Radiol. 2024. PMID: 38215532. doi:10.1016/j.ejrad.2024.111303
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。